National Research Council Canada-NRC

National Research Council Canada-NRC

August 20, 2009 14:00 ET

Government of Canada Supports Innovative Research and Development in Thunder Bay

THUNDER BAY, ONTARIO--(Marketwire - Aug. 20, 2009) - Mr. Greg Rickford, Member of Parliament for Kenora, on behalf of the Honourable Gary Goodyear, Minister of State (Science and Technology), today announced a contribution to Genesis Genomics Inc. from the National Research Council of Canada Industrial Research Assistance Program (NRC-IRAP).

The funding supports an innovative research and development project that will assist Genesis Genomics in early cancer detection.

"Our government is committed to building a competitive advantage for the Canadian private sector and supports these leading-edge technology solutions," said Mr. Rickford. "The Government of Canada is investing in science and technology to create jobs, strengthen the economy and improve Canadians' quality of life."

This $1,950,000 contribution will support the Thunder Bay-based company in a two-year project to identify diagnostic genetic cancer markers using mitochondrial DNA-based biomarkers.

"Investing in science and technology is critical for developing highly skilled people and improving the long-term competitiveness of Canadian firms," said NRC President Dr. Pierre Coulombe. "That's why NRC-IRAP is helping innovative Canadian businesses like Genesis Genomics grow stronger, faster and bigger."

Genesis Genomics Inc., based in Thunder Bay, is a biotechnology research pioneer in the discovery, development and commercial application of mitochondrial DNA (mtDNA) based biomarkers for a wide spectrum of human diseases. The company is launching a new project for "Accelerated mtDNA Genome Biomarker Discovery." This project, based on a new, novel class of mtDNA molecules, will develop screening tests for early detection of cancer which can lead to effective early treatment. The mitochondrion is responsible for many of the cellular processes associated with the growth of cancerous tumours; such early detection of cancerous tumours would greatly increase the opportunity for successful treatment and have a significant impact in improving the quality of life of Canadians.

"The only known cure for cancer is early detection. With the help of NRC-IRAP, we will position our company as the world leader in early detection and be able to provide Canadians with earlier cancer diagnosis and an improved prognosis as a result of early intervention," explained Robert Poulter, President and CEO of Genesis Genomics Inc.

About NRC and NRC-IRAP

The NRC Industrial Research Assistance Program (NRC-IRAP) provides a range of both technical and business-oriented advisory services along with necessary financial support to qualified innovative Canadian small- and medium-sized enterprises.

The program is delivered by a field staff of 240 professionals in more than 100 communities across Canada. NRC-IRAP is committed to working with small- and medium-sized enterprises while they realize their full potential, turning knowledge and innovation into strategic opportunities, jobs and prosperity for all Canadians.

The Government of Canada's Economic Action Plan has provided new resources of $200 million to NRC-IRAP over the next two years to support innovative Canadian firms. To learn more about Canada's Economic Action Plan, visit www.actionplan.gc.ca.

For more information (media only), please visit NRC-IRAP's Web site http://www.nrc-cnrc.gc.ca/eng/ibp/irap.html

Contact Information

  • National Research Council Canada
    Media Relations
    613-991-1431
    media@nrc-cnrc.gc.ca
    or
    Office of the Honourable Gary Goodyear
    Minister of State (Science and Technology)
    Gary Toft - Director of Communications
    613-943-7599